P rogramed cell death, apoptosis, is crucial for normal embryonic development, execution of immune functions, and elimination of damaged cells from an organism. Either increase or decrease in this process can result in pathological consequences. Apoptosis is transduced through death receptor pathway or mitochondrial pathway. 1 Both these pathways activate their own sets of caspases. 2 On FASL (FAS ligand) binding, the cytoplasmic tails of FAS recruit the adaptor protein FADD (Fas-associated protein with death domain), which activates caspase-8 and caspase-3 to degrade cellular components.
The relationship between apoptosis and atherosclerosis is complex, and both protective and harmful effects have been observed. 3 Vulnerable carotid plaque are characterized by high density of macrophages, and a study of sudden coronary death reported that apoptotic macrophages localize at the site of plaque rupture. 4 Activation of the apoptotic pathways has an important role in the acute phase after ischemic stroke. 5 However, prospective studies of the role of apoptosis for incidence of cardiovascular disease in humans have been prevented by the lack of valid biomarkers of apoptosis.
A recent study from the MDCS (Malmö Diet and Cancer Study) cohort demonstrated an association of FADD and caspase-8 with increased incidence of coronary events. 6 Experiments conducted in this study showed that apoptosis signaling activation via the Fas receptor leads to release of the intracellular apoptosis signaling components FADD, caspase-8, and caspase-3, indicating that these biomarkers reflect apoptotic activity. The present study aimed to assess the relationship between FADD, caspase-8, and caspase-3 and incidence of ischemic stroke.
Materials and Methods
Data are available on request by applying to MDCS steering committee (email: anders.dahlin@med.lu.se).
Study Population
The study is based on data from the MDCS cardiovascular cohort, studied between 1991 and 1994. Details of the cohort have been mentioned elsewhere. 6 Of the 6103 individuals, 5540 participants returned for fasting plasma collection. Subjects with missing data on FADD, caspase-3, and caspase-8 were excluded (n=365). Subsequently, subjects with a history of stroke (n=32) and with missing values for covariates (n=112) were also excluded. The final study population consisted of 4356 participants ( Figure I in the online-only Data Supplement).
All participants provided written informed consent. The study was approved by the regional ethical committee (LU51/90). Baseline Measurements
Baseline measurements are described in the online-only Data Supplement. The apoptotic biomarkers were analyzed in fasting EDTAplasma samples that had been stored in −80°C. FADD and caspase-3 were measured using the OLINK Proseek Multiplex Oncology Panel. Caspase-8 was measured in the OLINK Proseek Multiplex CVD Panel. They are expressed as arbitrary units (online-only Data Supplement). All participants were followed from the baseline measurements until the first stroke event, emigration from Sweden, death, or end of follow-up (December 31, 2014), whichever came first, by linkage with the Swedish population register and local and national patient registers. 7 In this study, 69% of all stroke cases were validated by review of hospital records.
Cox proportional hazard regression, with time in study as time scale, was used to compare the incidence of stroke across the quartiles of FADD, caspase-3, and caspase-8, with the lowest quartile (Q1) as the reference category, and per 1-SD increment of the logtransformed value. Hazard ratios with 95% CIs were calculated. Hazard ratios comparing Q4 versus Q1-Q3 were also calculated. Adjustment for covariates was performed in 3 models (Table) .
The association between apoptosis markers and stroke was explored in subgroups defined by sex, carotid plaque, age (above or below median, 57 years), and hypertension. Interactions were tested in the Cox models.
Results
During a mean follow-up period of 19.5±4.9 years, a total of 321 (7.4%) participants were diagnosed with ischemic stroke. Baseline characteristics of study participants with and without incident ischemic stroke are presented in Table I in the onlineonly Data Supplement. The relationship of the risk factors across the quartiles of FADD and caspase-8 is presented in Tables II and III in the online-only Data Supplement. Both FADD and caspase-8 were significantly associated with incidence of ischemic stroke (Table; Figures 1 and 2) . The associations remained significant after adjustment for risk factors (Table) . The multivariable-adjusted hazard ratios for Q4 versus Q1-Q3 of FADD and caspase-8 were 1.49 (95% CI, 1.18-1.87; P<0.01) and 1.77 (95% CI, 1.41-2.22; P<0.001), respectively. No such association was seen with caspase-3 (Table; Figure II in the online-only Data Supplement).
There was no significant interaction between FADD, caspase-8, and risk factors with regard to incident ischemic stroke. Results of the subgroup analyses are shown in Figures III and IV in the online-only Data Supplement.
Discussion
The results of the present study demonstrate that FADD and caspase-8, 2 markers of the extrinsic apoptotic pathway, are positively associated with incidence of ischemic stroke, even after adjustment for traditional risk factors and C-reactive protein. No such association was observed for caspase-3.
Atherosclerosis is a major risk factor for stroke. Increased apoptosis, in combination with reduced removal of defective and apoptotic cells, could increase the risk of plaque rupture. 8 It has been suggested that apoptosis is helpful in early stages of atherosclerosis, whereas in advanced lesions, it attributes 
Stroke

September 2018
to plaque instability and thrombosis. 9 Although no interaction was found for the presence of carotid plaque and high levels of FADD or caspase-8 on ischemic stroke incidence, the effect was somewhat stronger for those with carotid plaque, hence, suggesting that this can be a possible explanation.
One question is whether these plasma markers really reflect ongoing apoptotic activity. FADD, caspase-3, and caspase-8 are all intracellular proteins and parts of the apoptotic cascade. Previous experiments showed that all 3 proteins are released to the extracellular medium after apoptotic stimulation of mononuclear blood cells with FASL. 6 This suggests that plasma levels indeed reflect apoptosis. However, in contrast to FADD and caspase-8, caspase-3 was also released from peripheral mononuclear blood cells after exposure to a cytotoxic substance. This indicates that FADD and caspase-8 are more specific biomarkers for apoptosis than caspase-3, which also reflects other types of cell death.
To our knowledge, it is unknown whether apoptotic biomarkers or apoptotic activity reflects traits that are stable over time, such as genetic factors. Lind et al 10 conducted a study exploring the association of 85 cardiovascular proteins and incident ischemic stroke. They did not find any association between caspase-8 and stroke, which was observed in our study. FADD was not analyzed in their study.
The strength of this study is its large, prospective, and population-based study design with a long follow-up period. The stroke cases were obtained through linkages with local and national registers. Most cases were validated by review of medical records. A limitation of the study is the lack of serial measurements to assess changes in biomarkers and risk factors over time.
In conclusion, the results of this study suggest that elevated levels of FADD and caspase-8 are associated with increased incidence of ischemic stroke, independent of several potential confounding factors. Further studies are needed to understand the clinical implications of these apoptotic markers. 
